ABVIRO LLC

BETHESDA, MARYLAND 208142934

$8.01M
Total Contract Value
16 awards
First Award
Jun 23, 2022
Last Award
Sep 23, 2025
Business Size
small
CAGE Code
75YF3

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$8.74M7
541711$-379,044.777

Contract Awards

8 awards found

HHSN272201600028C
Department of Health and Human Services
$-229,705.02
Sep 23, 2025

THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2025
HHSN272201600028C
Department of Health and Human Services
$-34,173.06
Sep 13, 2024

THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
75N93023C00055
Department of Health and Human Services
$6.24M
Jul 1, 2024

TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93023C00055
Department of Health and Human Services
$755K
Feb 14, 2024

TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
HHSN272201600028C
Department of Health and Human Services
$-1,911.69
Sep 28, 2023

THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2023
75N93023C00055
Department of Health and Human Services
$1.75M
Sep 21, 2023

TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
HHSN272201600028C
Department of Health and Human Services
$9K
Jan 23, 2023

THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2023
HHSN272201600028C
Department of Health and Human Services
$-122,304.27
Sep 27, 2022

THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2022

Business Details

UEI
K3L6KXJ9B6M7
CAGE Code
75YF3
Address
4800 HAMPDEN LN STE 200
BETHESDA, MD 208142934
Congressional District
MD-08

Parent Company

ABVIRO LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov